Back
Regeneron Pharmaceuticals Vs. Eli Lilly and Industry Stock Comparison
Sell
39
REGN
Regeneron Pharmaceuticals
Last Price:
737.85
Seasonality Move:
14.6%
Sell
37
LLY
Eli Lilly and
Last Price:
747.82
Seasonality Move:
3.67%
Sell
39
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $738.00. The Score for REGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $748.01. The Score for LLY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- LLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $738.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $748.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing selling pressure, which indicates risk of future bearish movement.
REGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -60.82 | Sell |
Relative Strength Index (14 RSI): | 13.13 | Sell |
Chaikin Money Flow: | -973600 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (767.55 - 916.07) | Sell |
Bollinger Bands (100): | (904.84 - 1161.96) | Sell |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -37.29 | Sell |
Relative Strength Index (14 RSI): | 32.13 | Sell |
Chaikin Money Flow: | -2278865 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (761.68 - 879.8) | Sell |
Bollinger Bands (100): | (819.36 - 941.38) | Sell |
REGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 759.51 | Sell |
20-day SMA: | 815.56 | Sell |
50-day SMA: | 948.17 | Sell |
200-day SMA: | 1001.38 | Sell |
8-day EMA: | 761.76 | Sell |
20-day EMA: | 815.61 | Sell |
50-day EMA: | 913.33 | Sell |
200-day EMA: | 973.48 | Sell |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 756.56 | Sell |
20-day SMA: | 800.8 | Sell |
50-day SMA: | 865.08 | Sell |
200-day SMA: | 834.92 | Sell |
8-day EMA: | 759.78 | Sell |
20-day EMA: | 796.19 | Sell |
50-day EMA: | 842.15 | Sell |
200-day EMA: | 811.11 | Sell |
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.42 per share, and an increase next year of $0.41 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.88 per share, and an increase next year of $9.44 per share.
Regeneron Pharmaceuticals Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |